OCT 15, 2016 5:56 AM PDT

Brain Tumors: How Surgeons are Operating on the Inoperable

WRITTEN BY: Xuan Pham
Glioblastomas are notorious for being inoperable. That’s why when scientists developed a laser method to “cook” the tumor from the inside, they thought it was game-over for the malignant cancer. However, doctors soon discovered other problems – the tumor became swollen and endangered patients in other ways. Now, a combination technique may finally make it possible to effectively treat and remove the cancer.
 
Dubbed as the “octopus tumor,” GBMs are characterized with malignant glial cells forming vast networks of tendrils throughout the brain. This makes it nearly impossible to surgically remove all the cancerous tissues. As such, this brain cancer can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10 percent.
 
In 2013, Andrew Sloan and his colleagues pioneered a technique to treat the “inoperable” tumor. Since it would be difficult to remove it with conventional scalpels, Sloan and his team thought to kill the tumor by heating it up from the inside. They team developed a technique known as laser interstitial thermotherapy (LITT), which targets the laser to the tumor via a small hole in the scalp.
 
While LITT was successful at attacking the tumor, doctors soon found that the treatment led to swelling. This was especially dangerous for large tumors, where the deep swelling could seriously jeopardize a patient’s health.
 
So the surgeons had no choice but to operate on the inoperable. But in the course of this procedure, Dr. Sloan made a starling realization: the swollen, cooked tumor was mushy instead dense, and clean instead of bloody – the heat had apparently cauterized the tumor’s blood supply. This state of the tumor was amenable to being “sucked out” through a small hole in the skull, a craniotomy.
 

"I am very excited by the results of this study. This procedure is a new option for patients with these large malignant tumors," said Andrew Sloan, surgeon at the University Hospitals Case Medical Center, and lead author of the new study. "We have seen similar results and overall survival compared to LITT procedures performed in patients with smaller lesions and with lower risk."
 
The team has since performed this combination technique on 10 patients with extremely aggressive and intractable brain tumors, with promising results. Of the 10 patients, 6 remain alive with a median progression-free survival of 280 days, and a median overall survival of 482 days.
 
"We feel with further studies, LITT will continue to develop into a safer, more user-friendly technique that may help remove more of these deadly tumors than surgery alone can accomplish," said Sloan.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 23, 2020
Technology
Cyborg Technology Could Advance Diagnostics
AUG 23, 2020
Cyborg Technology Could Advance Diagnostics
Although it’s true, "cyborgs" are technically science fiction being the fact that they are part human an ...
SEP 03, 2020
Clinical & Molecular DX
Tiny Diagnostic Robot Tank Explores the Colon
SEP 03, 2020
Tiny Diagnostic Robot Tank Explores the Colon
The colon, also known as the large intestine, is where the final stages of digestion happen. Here, water, salts, and rem ...
SEP 02, 2020
Clinical & Molecular DX
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
SEP 02, 2020
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
Yawning in the middle of the day is completely normal for people with hectic schedules. How do you know whether it&rsquo ...
SEP 09, 2020
Clinical & Molecular DX
Swallow the Pill, Discover the Bugs Within
SEP 09, 2020
Swallow the Pill, Discover the Bugs Within
The 30-foot long human gastrointestinal tract consists of tissues and organs that work in concert to digest our food. Th ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
Loading Comments...